HALO logo
halo search icon
BioAtla, Inc.
BioAtla, Inc.
BCAB · NAS

BioAtla, Inc.

US$3.62

Price Arrow-0.25 (-6.46%)
20/05/2026 04:00:01 PM
All-CompaniesAll-ConsensusBig CandleBig Candle (Realtime)HALO AllHALO Consensus ValueHammer Bullish (Realtime)Near Support
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

BioAtla, Inc. Overview

BCAB Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Weak

Growth

Earnings

Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About BCAB

icon

Website

BioAtla, Inc.

icon

Telephone

1.858.558.0708

icon

Address

11085 Torreyana Road, San Diego, CA 92121

Description

BioAtla, Inc. engages in the development of novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its CAB portfolio include MABs & ADCS, BA3011, and BA3021. The company was founded by Jay M. Short and Carolyn Anderson in March 2007 and is headquartered in San Diego, CA.

BCAB Price Chart

Key Stats

Market Cap

US$6.42M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 3.26 - 71.5

Trade Value (12mth)

US$158,549.00

1 week

-9.37%

1 month

-31.38%

YTD

-85.51%

1 year

-79.75%

All time high

3831.50

Key Fundamentals

EPS 3 yr Growth

-63.00%

EBITDA Margin

NaN%

Operating Cashflow

-$48m

Free Cash Flow Return

0.00%

ROIC

0.00%

Interest Coverage

0.00

Quick Ratio

0.40

Other Data

Shares Outstanding (Fully Diluted)

2m

HALO Sector

Healthcare

Next Company Report Date

25-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

BCAB Announcements

Latest Announcements

DateAnnouncements
16 May 26
16 May 26
30 April 26
30 April 26
03 April 26

BCAB Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock-129.21-71.83-50.66locklocklock
EPS (Fully Diluted)
$locklocklocklock-129.21-71.83-50.66locklocklock
Growth
%locklocklocklock5.544.429.5locklocklock
PE
XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of BioAtla, Inc. (BCAB:NAS)?
Halo FAQ
The current share price of BioAtla, Inc. (BCAB:NAS) is USD$3.62.
What is the 52-week high share price for BioAtla, Inc. (BCAB:NAS)?
Halo FAQ
The 52-week high share price for BioAtla, Inc. (BCAB:NAS) is USD$71.50.
What is the 52-week low share price for BioAtla, Inc. (BCAB:NAS)?
Halo FAQ
The 52-week low share price for BioAtla, Inc. (BCAB:NAS) is USD$3.26.
What is the dividend yield for BioAtla, Inc. (BCAB:NAS)?
Halo FAQ
BioAtla, Inc. (BCAB:NAS) does not pay a dividend.
What was BioAtla, Inc. (BCAB:NAS) last dividend payment?
Halo FAQ
BioAtla, Inc. (BCAB:NAS) does not pay a dividend.
What is the franking level for BioAtla, Inc. (BCAB:NAS)?
Halo FAQ
BioAtla, Inc. (BCAB:NAS) has a franking level of 0.00%.
In which sector is BioAtla, Inc. (BCAB:NAS) classified?
Halo FAQ
BioAtla, Inc. (BCAB:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.